Pharmacological treatment for connective tissue disease-associated interstitial lung involvement: Protocol for an overview of systematic reviews and meta-analyses

Pharmacological treatment for connective tissue disease-associated interstitial lung involvement: Protocol for an overview of systematic reviews and meta-analyses

Show other versions (1)

<h4>Background</h4> Interstitial lung disease (ILD) is the most important pulmonary manifestation of connective tissue diseases (CTDs) since it is associated with high morbidity and mortality. However, there is uncertainty on what constitutes the optimal treatment options from a variety...

Full description

Bibliographic Details
Main Authors: Fotini B. Karassa, Konstantinos I. Bougioukas, Eleftherios Pelechas, Anastasia Skalkou, Evangelia Argyriou, Anna-Bettina Haidich
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348721/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348721/?tool=EBI

Similar Items